在非霍奇金淋巴瘤中CAR-T细胞治疗失败后的策略
Xiaotian Zhang1,2, Kailin Xu3,4, Robert Peter Gale5
1Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Bone marrow transplantation
|November 12, 2024
概括
CD19 CAR-T细胞疗法对B细胞癌症有前途,但复发很常见. 在失败后,很少有有效的治疗方法存在,这凸显了针对性干预和进一步研究的需要.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 已批准的CD19CAR-T细胞疗法在晚期B细胞癌症中显示出有效性.
- 主要耐药性疾病和复发仍然是CAR-T细胞治疗后的重大挑战.
研究的目的:
- 在B细胞非霍奇金淋巴瘤中批判性地分析CD19CAR-T细胞疗法的长期疗效数据.
- 确定与治疗疗效相关的因素,并探索复发的机制.
- 总结失败后疗法的结果,并评估它们的支持证据.
主要方法:
- 对B细胞非霍奇金淋巴瘤中CD19CAR-T细胞治疗的临床试验数据和现实世界的证据的全面审查.
- 对与治疗疗效相关的共同变异的分析.
- 系统评估CAR-T细胞衰竭后的干预措施,包括全移植,基于抗体的疗法和重复的CAR-T细胞输液.
主要成果:
- 有限的可靠数据支持大多数失败后的干预措施,而移植是显著的例外.
- 临床试验通常涉及小,异质的患者群体,随访时间短.
- 复发机制需要进一步阐明,以指导治疗策略.
结论:
- 对于在初始CAR-T细胞治疗后复发或耐药B细胞非霍奇金淋巴瘤患者的安全和有效疗法,存在着至关重要的未满足需求.
- 在CAR-T细胞衰竭后的干预措施必须根据治疗失败的具体原因进行个性化.
- 目前关于拯救疗法的证据,不包括全移植,基本上是不够的,需要进一步严格的调查.
相关概念视频
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K